Transfer and Evaluation of an Automated, Low-Cost Real-Time Reverse Transcription-PCR Test for Diagnosis and Monitoring of Human Immunodeficiency Virus Type 1 Infection in a West African Resource-Limited Setting

ABSTRACT There is an urgent need for low-cost human immunodeficiency virus type 1 (HIV-1) viral load (VL) monitoring technologies in resource-limited settings. An automated TaqMan real-time reverse transcription-PCR (RT-PCR) assay was transferred to the laboratory of the Centre de Diagnostic et de Recherches sur le SIDA, Abidjan, Côte d'Ivoire, and assessed for HIV-1 RNA VL testing in 806 plasma samples collected within four ANRS research programs. The detection threshold and reproducibility of the assay were first determined. The quantitative results obtained with this assay were compared with two commercial HIV-1 RNA kits (the Versant version 3.0 and Monitor version 1.5 assays) in specimens harboring mainly the circulating recombinant form 02 strain (CRF02). The clinical evaluation of this test was done in different situations including the early diagnosis of pediatric infection and the monitoring of antiretroviral-treated patients. The quantification limit of our method was 300 copies/ml. The HIV-1 RNA values obtained by real-time PCR assay were highly correlated with those obtained by the Versant kit (r = 0.901; P < 0.001) and the Monitor test (r = 0.856; P < 0.001) and homogeneously distributed according to HIV-1 genotypes. For the early diagnosis of pediatric HIV-1 infection, the sensitivity and specificity of the real-time PCR assay were both 100% (95% confidence intervals of 93.7 to 100.0 and 98.3 to 100.0, respectively), compared to the Versant results. Following initiation of antiretroviral treatment, the kinetics of HIV-1 RNA levels were very comparable, with a similar proportion of adults and children below the detection limit during follow-up with our technique and the Versant assay. The TaqMan real-time PCR ($12 per test) is now routinely used to monitor HIV-1 infection in our laboratory. This technology should be further evaluated in limited-resource countries where strains other than CRF02 are prevalent.

[1]  G. Marinos,et al.  Quantification of Hepatitis C Virus in Human Liver and Serum Samples by Using LightCycler Reverse Transcriptase PCR , 2002, Journal of Clinical Microbiology.

[2]  James Bethel,et al.  Performance Characteristics of HIV-1 Culture and HIV-1 DNA and RNA Amplification Assays for Early Diagnosis of Perinatal HIV-1 Infection , 2003, Journal of acquired immune deficiency syndromes.

[3]  R. Salamon,et al.  Clinical and Biological Evolution of HIV‐1 Seroconverters in Abidjan, Côte d’Ivoire, 1997‐2000 , 2002, Journal of acquired immune deficiency syndromes.

[4]  M. Re,et al.  Quantitative detection of human immunodeficiency virus type 1 (HIV-1) viral load by SYBR green real-time RT-PCR technique in HIV-1 seropositive patients. , 2004, Journal of virological methods.

[5]  Yuqi Zhao,et al.  Quantification of Human Immunodeficiency Virus Type 1 Proviral DNA by Using TaqMan Technology , 2002, Journal of Clinical Microbiology.

[6]  R. Salamon,et al.  Field Evaluation of an Improved Assay Using a Heat‐Dissociated p24 Antigen for Adults Mainly Infected With HIV‐1 CRF02_AG Strains in Côte d’Ivoire, West Africa , 2003, Journal of acquired immune deficiency syndromes.

[7]  S. Blanche,et al.  Highly active antiretroviral therapies among HIV-1-infected children in Abidjan, Côte d'Ivoire , 2004, AIDS.

[8]  D. Katzenstein,et al.  The evaluation of the HIV/AIDS Drug Access Initiatives in Côte D'Ivoire, Senegal and Uganda: how access to antiretroviral treatment can become feasible in Africa , 2003, AIDS.

[9]  Mark Dybul,et al.  Guidelines for Using Antiretroviral Agents among HIV-Infected Adults and Adolescents: The Panel on Clinical Practices for Treatment of HIV* , 2002, Annals of Internal Medicine.

[10]  T. Leitner,et al.  HIV‐1 viral load determination based on reverse transcriptase activity recovered from human plasma , 2003, Journal of medical virology.

[11]  T. Leitner,et al.  Improved HIV‐1 viral load determination based on reverse transcriptase activity recovered from human plasma , 2005, Journal of medical virology.

[12]  K. Nishioka,et al.  High throughput screening of 16 million serologically negative blood donors for hepatitis B virus, hepatitis C virus and human immunodeficiency virus type-1 by nucleic acid amplification testing with specific and sensitive multiplex reagent in Japan. , 2003, Journal of virological methods.

[13]  J. Braun,et al.  A new quantitative HIV load assay based on plasma virion reverse transcriptase activity for the different types, groups and subtypes , 2003, AIDS.

[14]  F. Brun-Vézinet,et al.  Plasma RNA Viral Load in Human Immunodeficiency Virus Type 2 Subtype A and Subtype B Infections , 2002, Journal of Clinical Microbiology.

[15]  R. Abramson,et al.  Detection of specific polymerase chain reaction product by utilizing the 5'----3' exonuclease activity of Thermus aquaticus DNA polymerase. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[16]  M. Peeters,et al.  Biological and genetic characteristics of HIV infections in Cameroon reveals dual group M and O infections and a correlation between SI-inducing phenotype of the predominant CRF02_AG variant and disease stage. , 2003, Virology.

[17]  E. Delaporte,et al.  Once-a-day highly active antiretroviral therapy in treatment-naive HIV-1-infected adults in Senegal , 2003, AIDS.

[18]  K. Fransen,et al.  Performance of a quantitative human immunodeficiency virus type 1 p24 antigen assay on various HIV-1 subtypes for the follow-up of human immunodeficiency type 1 seropositive individuals. , 2003, Journal of virological methods.

[19]  F. Dabis,et al.  HIV-1/AIDS and maternal and child health in Africa , 2002, The Lancet.

[20]  Yuqi Zhao,et al.  Quantification of Human Immunodeficiency Virus Type 1 RNA Levels in Plasma by Using Small-Volume-Format Branched-DNA Assays , 1998, Journal of Clinical Microbiology.

[21]  G L Andersen,et al.  Sequence-specific identification of 18 pathogenic microorganisms using microarray technology. , 2002, Molecular and cellular probes.

[22]  B. Irvine,et al.  Rapid and precise quantification of HIV-1 RNA in plasma using a branched DNA signal amplification assay. , 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[23]  F. Veglia,et al.  Calibrated Real-Time PCR Assay for Quantitation of Human Herpesvirus 8 DNA in Biological Fluids , 2002, Journal of Clinical Microbiology.

[24]  F. Dabis,et al.  Early diagnosis of paediatric HIV-1 infection among African breast-fed children using a quantitative plasma HIV RNA assay , 2001, AIDS.

[25]  Robert Oelrichs,et al.  Monitoring of human immunodeficiency virus infection in resource-constrained countries. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[26]  P. Roques,et al.  Plasma viral RNA assay in HIV-1 group O infection by real-time PCR. , 2003, Journal of virological methods.

[27]  C. Pasquier,et al.  HIV-1 subtyping using phylogenetic analysis of pol gene sequences. , 2001, Journal of virological methods.

[28]  R. Salamon,et al.  Presence of key drug resistance mutations in isolates from untreated patients of Abidjan, Côte d'Ivoire: ANRS 1257 study. , 2003, AIDS research and human retroviruses.

[29]  Sanjay Tyagi,et al.  Multiplex detection of four pathogenic retroviruses using molecular beacons. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[30]  C. Rouzioux,et al.  Monitoring Cytomegalovirus Infection in Adult and Pediatric Bone Marrow Transplant Recipients by a Real-Time PCR Assay Performed with Blood Plasma , 2003, Journal of Clinical Microbiology.

[31]  T. Chan,et al.  Rapid quantification of hepatitis B virus DNA by real-time PCR using fluorescent hybridization probes. , 2003, Journal of medical microbiology.

[32]  Alimuddin Zumla,et al.  Whole blood versus plasma spots for measurement of HIV-1 viral load in HIV-infected African patients , 2003, The Lancet.

[33]  T. Leitner,et al.  A multiplex real‐time PCR for quantification of HIV‐1 DNA and the human albumin gene in CD4+ cells , 2003, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[34]  A. Lézin,et al.  Quantitation of HTLV-I proviral load by a TaqMan real-time PCR assay. , 2002, Journal of virological methods.

[35]  H. Niesters.  Quantitation of viral load using real-time amplification techniques. , 2001, Methods.

[36]  C. Rouzioux,et al.  Real-time blood plasma polymerase chain reaction for management of disseminated adenovirus infection. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[37]  F. Dabis,et al.  Field Evaluation of a Rapid Human Immunodeficiency Virus (HIV) Serial Serologic Testing Algorithm for Diagnosis and Differentiation of HIV Type 1 (HIV-1), HIV-2, and Dual HIV-1-HIV-2 Infections in West African Pregnant Women , 2004, Journal of Clinical Microbiology.

[38]  T. Hirose,et al.  Automated Multiplex Assay System for Simultaneous Detection of Hepatitis B Virus DNA, Hepatitis C Virus RNA, and Human Immunodeficiency Virus Type 1 RNA , 2001, Journal of Clinical Microbiology.

[39]  C. Rouzioux,et al.  HIV-1 RNA detection in plasma for the diagnosis of infection in neonates. The French Pediatric HIV Infection Study Group. , 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[40]  W. Rozenbaum,et al.  Quantification of Human Immunodeficiency Virus Type 1 Proviral Load by a TaqMan Real-Time PCR Assay , 2001, Journal of Clinical Microbiology.

[41]  John W. Mellors,et al.  New Real-Time Reverse Transcriptase-Initiated PCR Assay with Single-Copy Sensitivity for Human Immunodeficiency Virus Type 1 RNA in Plasma , 2003, Journal of Clinical Microbiology.

[42]  R. Salamon,et al.  Medium-Term Survival, Morbidity and Immunovirological Evolution in HIV-Infected Adults Receiving Antiretroviral Therapy, Abidjan, Côte D'Ivoire , 2002, Antiviral therapy.

[43]  D. Altman,et al.  Comparing methods of measurement: why plotting difference against standard method is misleading , 1995, The Lancet.